⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer

Official Title: Phase 2 Open-Label, Multicenter Clinical Study of the Safety and Efficacy of Intravenous Administration of SNS-595 in Patients With Advanced Small Cell Lung Cancer (SCLC)

Study ID: NCT00298896

Interventions

SNS-595

Study Description

Brief Summary: The purpose of this study is to evaluate the objective tumor response rate to SNS-595 in patients with small cell lung cancer (SCLC).

Detailed Description: Other objectives of this study are to assess the safety, survival rate, best response, time to disease progression, duration of tumor response, and to explore several potential biomarkers to see how these levels change after administration of SNS-595.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of California Davis, Sacramento, California, United States

Stanford University Medical Center, Stanford, California, United States

Rush University Medical Center, Chicago, Illinois, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Duke University Medical Center, Durham, North Carolina, United States

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Sarah Cannon Research Institute, Nashville, Tennessee, United States

The Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Cross Cancer Institute, Edmonton, Alberta, Canada

BC Cancer Agency, Vancouver, British Columbia, Canada

Juravinski Cancer Centre, Hamilton, Ontario, Canada

Hopital Charles LeMoyne, Greenfield Park, Quebec, Canada

Hopital Laval, Sainte-Foy, Quebec, Canada

Contact Details

Name: Craig Berman, MD

Affiliation: Sunesis Pharmaceuticals

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: